Anticancer activity of Salvia officinalis essential oil against HNSCC cell line (UMSCC1)
- Publication type:
- Journal article
- Metadata:
-
- Autoren
- S Sertel
- T Eichhorn
- PK Plinkert
- T Efferth
- Autoren-URL
- https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=fis-test-1&SrcAuth=WosAPI&KeyUT=WOS:000297867900008&DestLinkType=FullRecord&DestApp=WOS_CPL
- DOI
- 10.1007/s00106-011-2274-3
- Externe Identifier
- Clarivate Analytics Document Solution ID: 859HQ
- PubMed Identifier: 21894557
- ISSN
- 0017-6192
- Ausgabe der Veröffentlichung
- 12
- Zeitschrift
- HNO
- Schlüsselwörter
- Mouth neoplasms
- Salvia officinalis
- Plant oils
- Cytotoxicity
- Microarray analysis
- Paginierung
- 1203 - 1208
- Datum der Veröffentlichung
- 2011
- Status
- Published
- Titel
- Anticancer activity of Salvia officinalis essential oil against HNSCC cell line (UMSCC1)
- Sub types
- Article
- Ausgabe der Zeitschrift
- 59
Data source: Web of Science (Lite)
- Other metadata sources:
-
- Autoren
- S Sertel
- T Eichhorn
- PK Plinkert
- T Efferth
- DOI
- 10.1007/s00106-011-2274-3
- eISSN
- 1433-0458
- ISSN
- 0017-6192
- Ausgabe der Veröffentlichung
- 12
- Zeitschrift
- HNO
- Sprache
- de
- Online publication date
- 2011
- Paginierung
- 1203 - 1208
- Datum der Veröffentlichung
- 2011
- Status
- Published
- Herausgeber
- Springer Science and Business Media LLC
- Herausgeber URL
- http://dx.doi.org/10.1007/s00106-011-2274-3
- Datum der Datenerfassung
- 2019
- Titel
- Krebshemmende Wirkung des ätherischen Salbei-Öls auf eine Plattenepithelzellkarzinom-Zelllinie der Mundhöhle (UMSCC1)
- Ausgabe der Zeitschrift
- 59
Data source: Crossref
- Abstract
- <h4>Background</h4>Every year there are several hundred thousand new cases of oral cancer worldwide. Clinical oncology is still challenged by toxicity and side effects of multimodal therapy strategies in which is associated with poor prognosis for patients. There is an urgent necessity to develop novel therapy strategies. As the majority of anticancer drugs are of natural origin, natural products represent a valuable source for the identification and development of novel treatment options for cancer. The aim of this investigation was to study the cytotoxicity of Salvia officinalis L. (sage) essential oil.<h4>Methods</h4>Salvia officinalis essential oil was gained by aqueous extraction from plant material and subsequently analyzed by gas chromatography. The cytotoxicity of the essential oil on the squamous human cell carcinoma cell line of the oral cavity (UMSCC1) was assessed with the XTT assay. These experiments revealed the half maximal inhibitory concentration (IC(50)) of the essential oil. It was used in the microarray-based analysis of gene expression of UMSSC1 cells. The results were submitted to a signaling pathway analysis.<h4>Results</h4>The main constituents of Salvia officinalis essential oil include the monoterpenes thujone, β-pinene, and 1,8-cineol. Low concentrations of the essential oil increased vitality of the UMSCC1 cells. Beyond the concentration of the IC(50) of 135 µg/ml, sage essential oil reduced UMSSC1 cells viability to a minimum. In the microarray gene expression analysis, genes involved in cancer, cellular growth and proliferation, cell death, cell morphology, cell cycle, gene expression, and DNA repair were the most prominent. The three most significantly regulated pathways by sage were aryl hydrocarbon receptor signaling, cell cycle (G1/S checkpoint) regulation, and p53 signaling.<h4>Conclusion</h4>To the best of our knowledge, this study suggests for the first time the ability of Salvia officinalis essential oil to inhibit human HNSCC cell growth. The therapeutic potential of sage essential oil might exceed that of its common use in otorhinolaryngology.
- Addresses
- Hals-, Nasen- und Ohrenklinik, Universität Heidelberg, Deutschland. serkan.sertel@med.uni-heidelberg.de
- Autoren
- S Sertel
- T Eichhorn
- PK Plinkert
- T Efferth
- T Efferth
- DOI
- 10.1007/s00106-011-2274-3
- eISSN
- 1433-0458
- Externe Identifier
- PubMed Identifier: 21894557
- Open access
- false
- ISSN
- 0017-6192
- Ausgabe der Veröffentlichung
- 12
- Zeitschrift
- HNO
- Schlüsselwörter
- Cell Line, Tumor
- Humans
- Salvia officinalis
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Oils, Volatile
- Plant Extracts
- Antineoplastic Agents, Phytogenic
- Treatment Outcome
- Apoptosis
- Cell Survival
- Dose-Response Relationship, Drug
- Sprache
- ger
- Medium
- Paginierung
- 1203 - 1208
- Datum der Veröffentlichung
- 2011
- Status
- Published
- Datum der Datenerfassung
- 2011
- Titel
- [Anticancer activity of Salvia officinalis essential oil against HNSCC cell line (UMSCC1)].
- Sub types
- Journal Article
- English Abstract
- Ausgabe der Zeitschrift
- 59
Data source: Europe PubMed Central
- Abstract
- BACKGROUND: Every year there are several hundred thousand new cases of oral cancer worldwide. Clinical oncology is still challenged by toxicity and side effects of multimodal therapy strategies in which is associated with poor prognosis for patients. There is an urgent necessity to develop novel therapy strategies. As the majority of anticancer drugs are of natural origin, natural products represent a valuable source for the identification and development of novel treatment options for cancer. The aim of this investigation was to study the cytotoxicity of Salvia officinalis L. (sage) essential oil. METHODS: Salvia officinalis essential oil was gained by aqueous extraction from plant material and subsequently analyzed by gas chromatography. The cytotoxicity of the essential oil on the squamous human cell carcinoma cell line of the oral cavity (UMSCC1) was assessed with the XTT assay. These experiments revealed the half maximal inhibitory concentration (IC(50)) of the essential oil. It was used in the microarray-based analysis of gene expression of UMSSC1 cells. The results were submitted to a signaling pathway analysis. RESULTS: The main constituents of Salvia officinalis essential oil include the monoterpenes thujone, β-pinene, and 1,8-cineol. Low concentrations of the essential oil increased vitality of the UMSCC1 cells. Beyond the concentration of the IC(50) of 135 µg/ml, sage essential oil reduced UMSSC1 cells viability to a minimum. In the microarray gene expression analysis, genes involved in cancer, cellular growth and proliferation, cell death, cell morphology, cell cycle, gene expression, and DNA repair were the most prominent. The three most significantly regulated pathways by sage were aryl hydrocarbon receptor signaling, cell cycle (G1/S checkpoint) regulation, and p53 signaling. CONCLUSION: To the best of our knowledge, this study suggests for the first time the ability of Salvia officinalis essential oil to inhibit human HNSCC cell growth. The therapeutic potential of sage essential oil might exceed that of its common use in otorhinolaryngology.
- Autoren
- S Sertel
- T Eichhorn
- PK Plinkert
- T Efferth
- Autoren-URL
- https://www.ncbi.nlm.nih.gov/pubmed/21894557
- DOI
- 10.1007/s00106-011-2274-3
- eISSN
- 1433-0458
- Ausgabe der Veröffentlichung
- 12
- Zeitschrift
- HNO
- Schlüsselwörter
- Antineoplastic Agents, Phytogenic
- Apoptosis
- Carcinoma, Non-Small-Cell Lung
- Cell Line, Tumor
- Cell Survival
- Dose-Response Relationship, Drug
- Humans
- Lung Neoplasms
- Oils, Volatile
- Plant Extracts
- Salvia officinalis
- Treatment Outcome
- Sprache
- ger
- Country
- Germany
- Paginierung
- 1203 - 1208
- Datum der Veröffentlichung
- 2011
- Status
- Published
- Datum, an dem der Datensatz öffentlich gemacht wurde
- 2012
- Titel
- [Anticancer activity of Salvia officinalis essential oil against HNSCC cell line (UMSCC1)].
- Sub types
- English Abstract
- Journal Article
- Ausgabe der Zeitschrift
- 59
Data source: PubMed
- Beziehungen:
- Property of